FDA inspection
Gland Pharma Limited: FDA inspection ending Jul 26, 2016
FDA inspection 981298 · No Action Indicated (NAI) · Medchal-Malkajgiri District, Hyderabad
Key facts
| Inspection ID | 981298 |
|---|---|
| Firm | Gland Pharma Limited |
| FEI number | 3002647489 |
| Address | Survey 143-148, 150-151 Gandimaisamma, Cross Road, D P Pally, Quthubullapur |
| City | Medchal-Malkajgiri District, Hyderabad |
| Fiscal year | 2016 |
| Inspection end date | Jul 26, 2016 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data